UBS Evidence Lab data, which tracks iPhone availability across 30 geographies, suggests wait times for the iPhone 17 lineup continue the trend of flattish to lower week over week across key geographies, UBS tells investors in a research note. Wait times on a year over year basis are relatively flattish, excluding the base model, the firm says. Additionally, UBS says wait times for the Air are about 11 days following approval in China. UBS has a Neutral rating and $220 price target on Apple (AAPL) shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AAPL:
- ‘Paramount Can Walk Away with Warner Bros.’ Say TD Cowen and Benchmark Analysts
- Apple attacks EU over Digital Markets Act, Bloomberg reports
- Meta tops tech lobbying spending in Q3, Axios reports
- Apple Stock: Big iPhone Adoption Cycle Merits Street-High Price Target, Says Loop Capital
- Samsung and Google Take on Apple and Meta in the XR Headset Race